Atara Biotherapeutics, Inc. (ATRA)
8.87
+0.53
(+6.35%)
USD |
NASDAQ |
May 11, 16:00
9.50
+0.63
(+7.10%)
After-Hours: 18:06
Atara Biotherapeutics EPS Diluted (Quarterly) : -0.465 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1341 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.406M |
| Revenue (Quarterly) | 1.595M |
| Total Expenses (Quarterly) | 5.001M |
| Enterprise Value | 112.52M |
| Gross Profit Margin (Quarterly) | 93.48% |
| Profit Margin (Quarterly) | -213.5% |
| Earnings Yield | 32.86% |
| Operating Earnings Yield | 46.96% |
| Normalized Earnings Yield | 42.33 |